S 3302 · in committee · significant
Mikaela Naylon Give Kids a Chance Act of 2025
- healthcare
What this bill does
- The bill allows clinical trials combining new drugs with existing approved cancer treatments for pediatric cancer patients.
- Pediatric cancer researchers and pharmaceutical companies developing drugs for rare childhood diseases are affected.
- The bill renews FDA voucher incentives through 2030 and requires progress reports on drug development outcomes.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would allowing combination trials of experimental drugs with approved cancer treatments change the speed at which new pediatric cancer therapies reach patients?
- 02
What safeguards should be in place to ensure children in these combination trials are protected from increased risks of untested drug interactions?
- 03
Why does the bill extend FDA voucher incentives through 2030, and what evidence shows this approach encourages pharmaceutical investment in rare childhood diseases?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-OK
Markwayne Mullin
Citizen cosponsors
0
In Congress
37/ 100
Senators cosponsoring
Introduced 2025-12-02
Joining the bill
James C. Justice
R-WV · original
Amy Klobuchar
D-MN · original
Cory A. Booker
D-NJ · original
Jon Husted
R-OH · original
John Boozman
R-AR · original
Susan M. Collins
R-ME · original
Shelley Moore Capito
R-WV · original
Christopher A. Coons
D-DE · original
Michael F. Bennet
D-CO · original
John W. Hickenlooper
D-CO · original
Tammy Duckworth
D-IL · original
Mark Kelly
D-AZ · original
+ 25 more
Legislative timeline
2025-12-02 · senate · IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2025-12-02 · IntroReferral
Introduced in Senate
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.